Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1,107.74% | 773.06% | 43.03% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,107.74% | 773.06% | 43.03% | -- | -- |
| Cost of Revenue | 714.81% | 1,202.98% | 727.92% | -- | -- |
| Gross Profit | -607.99% | -1,348.63% | -5,924.72% | -- | -- |
| SG&A Expenses | -21.32% | -17.29% | -35.67% | -27.33% | -1.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 84.46% | 43.82% | 39.35% | 2.37% | -5.10% |
| Operating Income | -49.37% | -30.40% | -38.86% | -0.16% | 8.24% |
| Income Before Tax | -101.25% | -51.09% | -83.86% | -2.44% | 14.64% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -101.25% | -51.09% | -83.86% | -2.44% | 14.64% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.25% | -51.09% | -83.86% | -2.44% | 14.64% |
| EBIT | -49.37% | -30.40% | -38.86% | -0.16% | 8.24% |
| EBITDA | 6.42% | -32.33% | -40.56% | -0.85% | 9.52% |
| EPS Basic | -13.09% | 15.36% | -2.96% | 34.91% | 27.18% |
| Normalized Basic EPS | -13.07% | 15.35% | -2.91% | 34.93% | 27.18% |
| EPS Diluted | -13.09% | 15.36% | -2.96% | 34.91% | 27.18% |
| Normalized Diluted EPS | -13.07% | 15.35% | -2.91% | 34.93% | 27.18% |
| Average Basic Shares Outstanding | 77.94% | 78.49% | 78.59% | 57.44% | 17.21% |
| Average Diluted Shares Outstanding | 77.94% | 78.49% | 78.59% | 57.44% | 17.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |